| Lastest Insider Transactions Of Outlook Therapeutics, Inc. ( OTLK ) |
| Symbol | Company Name | Insider Name | Title | Date | Transation | Share | Price | Amount | File Date |
| OTLK | Outlook Therapeutics, Inc. | Sukhtian Ghiath M. | Directior 10% Owner | 2025-01-17 | Option Exercise | 3,458,571 | 2.51 | 8,681,013 | 2025-03-12 20:56:07 |
| OTLK | Outlook Therapeutics, Inc. | KENYON LAWRENCE A | Chief Financial Officer | 2024-09-26 | Buy | 5,000 | 5.69 | 28,446 | 2024-09-30 16:53:23 |
| OTLK | Outlook Therapeutics, Inc. | Syntone Ventures LLC | 10% Owner | 2024-04-15 | Buy | 714,286 | 0.00 | 0 | 2024-04-17 20:21:17 |
| OTLK | Outlook Therapeutics, Inc. | Haddadin Yezan Munther | Directior | 2024-03-28 | Buy | 1,881 | 11.82 | 22,242 | 2024-03-29 10:39:09 |
| OTLK | Outlook Therapeutics, Inc. | Evanson Jeff | CHIEF COMMERCIAL OFFICER | 2024-03-07 | Buy | 62,484 | 0.42 | 26,243 | 2024-03-11 16:43:10 |
| OTLK | Outlook Therapeutics, Inc. | Dagnon Terry | Chief Operations Officer | 2023-04-20 | Sell | 520,000 | 1.14 | 590,200 | 2023-04-21 21:05:47 |
| OTLK | Outlook Therapeutics, Inc. | Evanson Jeff | Chief Commercial Officer | 2023-01-20 | Sell | 267,000 | 1.11 | 296,370 | 2023-01-24 20:08:49 |
| OTLK | Outlook Therapeutics, Inc. | Evanson Jeff | Chief Commercial Officer | 2023-01-17 | Sell | 164,155 | 1.24 | 203,726 | 2023-01-19 20:05:42 |
